December 16, 2022 12:14 PM ESTUpdated 03:27 PM
Pharma
Law

As­traZeneca nabs 6 more months for Sym­bi­cort patent in lat­est court rul­ing

Beth Snyder Bulik

Senior Editor

A fed­er­al judge in West Vir­ginia ruled in fa­vor of As­traZeneca on Wednes­day, adding six months of patent pro­tec­tion for its asth­ma and COPD in­haler …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

HHS says it's pulled Covid shot guid­ance for healthy kids. The CDC vac­cine sched­ule shows oth­er­wise

Up­dat­ed: Pa­tient dies in Rock­et gene ther­a­py tri­al, which is put on clin­i­cal hold by FDA

Lil­ly to buy non-opi­oid pain biotech SiteOne for up to $1B

Ver­tex touts promis­ing first few months of launch for non-opi­oid pain drug Jour­navx

Ver­tex's next chal­lenge for pain pill? Crack­ing a mar­ket dom­i­nat­ed by cheap opi­oids

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times